Agilent Technologies, Inc. (NYSE:A) Stock Position Decreased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. trimmed its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 9.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 676,275 shares of the medical research company's stock after selling 73,292 shares during the period. Envestnet Asset Management Inc. owned approximately 0.24% of Agilent Technologies worth $90,851,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of A. CKW Financial Group lifted its stake in Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock valued at $25,000 after buying an additional 100 shares during the last quarter. Global X Japan Co. Ltd. raised its position in Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock valued at $25,000 after purchasing an additional 116 shares during the last quarter. Lee Danner & Bass Inc. acquired a new stake in Agilent Technologies during the 4th quarter worth $29,000. Hanson & Doremus Investment Management boosted its stake in Agilent Technologies by 66.5% during the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after purchasing an additional 105 shares during the period. Finally, OFI Invest Asset Management purchased a new position in Agilent Technologies during the 4th quarter worth $37,000. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Agilent Technologies Price Performance

Agilent Technologies stock traded up $3.23 during trading hours on Monday, hitting $105.94. The stock had a trading volume of 462,046 shares, compared to its average volume of 2,079,918. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. The stock's fifty day moving average is $123.76 and its two-hundred day moving average is $133.84. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $155.35. The stock has a market capitalization of $30.20 billion, a price-to-earnings ratio of 24.35, a PEG ratio of 2.89 and a beta of 1.19.

Remove Ads

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $1.68 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. As a group, analysts predict that Agilent Technologies, Inc. will post 5.55 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.94%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.76%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on A shares. Citigroup increased their target price on shares of Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research note on Thursday, December 19th. Barclays decreased their price objective on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a research report on Thursday. TD Cowen boosted their target price on Agilent Technologies to $135.00 and gave the company a "buy" rating in a report on Thursday. StockNews.com raised Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Finally, Robert W. Baird dropped their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a research note on Thursday, February 27th. Seven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Agilent Technologies has an average rating of "Moderate Buy" and an average price target of $146.25.

Insiders Place Their Bets

In related news, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. This represents a 4.84 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of the firm's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares in the company, valued at approximately $2,657,456.28. This represents a 8.05 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,638 shares of company stock valued at $731,229. Insiders own 0.26% of the company's stock.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.